Seal Rock Therapeutics
Biotechnology-Research
Website
Company Tagline
Clinical-stage company developing novel therapeutics for diseases of high unmet need of the liver and nervous system
Industry Category
Business Keywords
Company Description
Seal Rock Therapeutics is a dynamic biotechnology research company dedicated to developing innovative therapeutics for diseases with significant unmet medical needs, particularly in the liver and nervous system. Seal Rock Therapeutics is committed to pioneering advancements in the treatment of debilitating conditions through cutting-edge research and development. Located at 600 Stewart St, Seattle, Washington 98101, US, Seal Rock Therapeutics focuses on creating novel solutions that can improve patient outcomes and transform lives.
Seal Rock Therapeutics specializes in LRRK2/ASK1 signaling complex (LASC) inhibitors, which are designed as disease-modifying agents for Parkinson's disease and ALS. By targeting multiple causal pathways and severing feedback loops that contribute to neurodegeneration and neuroinflammation, Seal Rock Therapeutics aims to provide effective treatments for these challenging conditions. With the ASK1 inhibitor SRT-015 showing promising safety and efficacy in phase 1 trials, Seal Rock Therapeutics is actively developing oral SRT-015 for cirrhosis and rare liver diseases.
Seal Rock Therapeutics continues to explore additional opportunities with ASK1 inhibitors, including potential applications in cardiac, immunological, and neurodegenerative indications. The company’s commitment to innovation and patient care drives its ongoing efforts to develop and deliver groundbreaking therapies. Seal Rock Therapeutics is dedicated to making a meaningful impact on global health. We invite the manager of Seal Rock Therapeutics to create a customized and exclusive company showcase and product listing on our platform.
Seal Rock Therapeutics est une entreprise dynamique de recherche biotechnologique dédiée au développement de thérapies innovantes pour les maladies présentant d'importants besoins médicaux non satisfaits, en particulier au niveau du foie et du système nerveux. Seal Rock Therapeutics s'engage à faire progresser le traitement des affections invalidantes grâce à la recherche et au développement de pointe. Située au 600 Stewart St, Seattle, Washington 98101, États-Unis, Seal Rock Therapeutics se concentre sur la création de solutions novatrices susceptibles d'améliorer les résultats pour les patients et de transformer des vies.
Seal Rock Therapeutics est spécialisée dans les inhibiteurs du complexe de signalisation LRRK2/ASK1 (LASC), conçus comme agents modificateurs de la maladie de Parkinson et de la SLA. En ciblant de multiples voies causales et en interrompant les boucles de rétroaction qui contribuent à la neurodégénérescence et à la neuroinflammation, Seal Rock Therapeutics vise à fournir des traitements efficaces pour ces affections difficiles. Avec l'inhibiteur ASK1 SRT-015 qui a démontré une innocuité et une efficacité prometteuses lors des essais de phase 1, Seal Rock Therapeutics développe activement le SRT-015 oral pour la cirrhose et les maladies rares du foie.
Seal Rock Therapeutics continue d'explorer d'autres opportunités avec les inhibiteurs ASK1, y compris les applications potentielles dans les indications cardiaques, immunologiques et neurodégénératives. L'engagement de l'entreprise envers l'innovation et les soins aux patients motive ses efforts continus pour développer et fournir des thérapies révolutionnaires. Seal Rock Therapeutics se consacre à avoir un impact significatif sur la santé mondiale. Nous invitons le directeur de Seal Rock Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Seal Rock Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Seal Rock TherapeuticsMain Company |
NeuroplastView Profile |
Herantis Pharma Plc.View Profile |
AC ImmuneView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2008 | 2003 |
|
Company Size
|
— | 11-50 | 11-50 | 51-200 |
|
City
|
Seattle, Washington | Geleen, Limburg | Espoo, Southern Finland | Lausanne, Vaud |
|
Country
|
United States | Netherlands | Finland | Switzerland |
|
Skills & Keywords
Comparing with main company
|
16 Total Skills
Biotechnology
Therapeutics
Liver Diseases
Nervous System
Parkinson's Disease
ALS
ASK1 Inhibitors
Neurodegenerative diseases
Orphan liver
Cirrhosis
Liver disease
Inflammation
ASK1
Parkinson's disease
LRRK2
Fibrosis
|
11 Total
11 Unique
Unique Skills:
Fast-track development programs
Frontotemporal dementia
GMP - Good Manufacturing Practice
Living medicine
MS
Neuro-Cells (r)
+5
|
3 Total
3 Unique
Unique Skills:
Biologics
biotech
drug development
|
6 Total
1 Common
5 Unique
Match
6%
Common Skills:
Therapeutics
Unique Skills:
Alzheimer's disease
Diagnostics
Down syndrome
Misfolded proteins
Neuro-orphan diseases
|
4
Total Companies2003
Oldest Founded4
Countries35
Unique SkillsSimilar Companies
Other organizations in the same industry
ULT - Unifying Life Tech
Biotechnology-Research“Inner Journeys, Shared Worlds.” Biotechnology for conscious healing.
CompreVie
Biotechnology-ResearchNext-generation organ-on-chip technology for human-accurate safety & efficacy prediction.
Bishop Simon
Biotechnology-ResearchWe take a pragmatic approach to help your business achieve compliance
Alternative Company Names
This company is also known as